Differential alterations in mitochondrial function induced by a choline-deficient diet: Understanding fatty liver disease progression

Mitochondrion

Volumn 8, Issue 5-6, 2008, Pages 367-376

  Teodoro, João S ^a   Rolo, Anabela P ^a   Duarte, Filipe V ^a   Simões, Anabela M ^a   Palmeira, Carlos M ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Adenine nucleotide translocator; Fatty liver; Mitochondria; Mitochondrial permeability transition; Oxidative phosphorylation

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; ADENOSINE TRIPHOSPHATASE; CALCIUM; CHOLINE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; LIPID STORAGE; LIVER MITOCHONDRION; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; MITOCHONDRIAL RESPIRATION; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

ANIMALS; CHOLINE DEFICIENCY; DISEASE PROGRESSION; FATTY LIVER; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA, LIVER; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MITOCHONDRIAL PROTEINS; OXYGEN CONSUMPTION; RATS; RATS, WISTAR;

ANIMALIA;

EID: 54949089576     PISSN: 15677249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mito.2008.07.008     Document Type: Article

References (44)

1. Baffy G., Zhang C.Y., Glickman J.N., and Lowell B.B. Obesity-related fatty liver is unchanged in mice deficient for mitochondrial uncoupling protein 2. Hepatology 35 (2002) 753-761
2. Begriche K., Igoudjil A., Pessayre D., and Fromenty B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 1 (2006) 1-28
3. Brautigan D.L., Ferguson-Miller S., and Margoliash E. Mitochondrial cytochrome c: preparation and activity of native and chemically modified cytochrome c. Methods in Enzymology 53 (1978) 128-133
4. Brealey D., Brand M., Hargreaves I., Heales S., Land J., Smolenski R., Davies N.A., Cooper C.E., and Singer M. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360 (2002) 219-223
5. Browning J.D., and Horton J.D. Molecular mediators of hepatic steatosis and liver injury. The Journal of Clinical Investigation 114 (2004) 147-152
6. Caldwell S.H., Chang C.Y., Nakamoto R.K., and Krugner-Higby L. Mitochondria in non-alcoholic fatty liver disease. Clinics in Liver Disease 8 (2004) 595-617
7. Chitturi S., and Farrell G.C. Etiopathogenesis of nonalcoholic steatohepatitis. Seminars in Liver Disease 21 (2001) 27-41
8. Clark J.M., and Diehl A.M. Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. The Journal of the American Medical Association 289 (2003) 3000-3004
9. Danzani M.U. Uncoupling of oxidative phosphorylation in mitochondria from fatty livers. The Biochemical Journal 65 (1957) 116-124
10. Day C.P., and James O.F. Hepatic steatosis: innocent bystander or guilty party?. Hepatology 27 (1998) 1463-1466
11. DiMauro S., and Schon E.A. Mitochondrial respiratory-chain diseases. The New England Journal of Medicine 348 (2003) 2656-2668
12. Diraison F., Yankah V., Letexier D., Dusserre E., Jones P., and Beylot M. Differences in the regulation of adipose tissue and liver lipogenesis by carbohydrates in humans. Journal of Lipid Research 44 (2003) 846-853
13. Donthamsetty S., Bhave V.S., Mitra M.S., Latendresse J.R., and Mehendale H.M. Nonalcoholic fatty liver sensitizes rats to carbon tetrachloride hepatotoxicity. Hepatology 45 (2007) 391-403
14. Douette P., Navet R., Gerkens P., de Pauw E., Leprince P., Sluse-Goffart C., and Sluse F.E. Steatosis-induced proteomic changes in liver mitochondria evidenced by two dimensional differential in-gel electrophoresis. Journal of Proteome Research 4 (2005) 2024-2031
15. Duchen M.R. Mitochondria in health and disease: perspectives on a new mitochondrial biology. Molecular Aspects of Medicine 25 (2004) 365-451
16. Estabrook R.W. Mitochondrial respiratory control and the polarographic measurements of ADP/O ratios. Methods in Enzymology 10 (1967) 41-47
17. Fromenty B., and Pessayre D. Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines. Journal of Hepatology 26 (1997) 43-53
18. Gazotti P., Malmstrom K., and Brdiczka D. Membrane Biochemistry: A Laboratory Manual on Transport and Bioenergetics (1979), Springer-Verlag, New York pp. 62-69
19. Gornall A.G., Bardawill C.J., and David M.M. Determination of serum proteins by means of the biuret reaction. The Journal of Biological Chemistry 177 (1949) 751-766
20. Grattagliano I., Caraceni P., Portincasa P., Domenicali M., Palmieri V.O., Trevisani F., Bernardi M., and Palasciano G. Adaptation of subcellular glutathione detoxification system to stress conditions in choline-deficient diet induced rat fatty liver. Cell Biology and Toxicology 19 (2003) 355-366
21. Haque M., and Sanyal A. The metabolic abnormalities associated with non-alcoholic fatty liver disease. Best Practice & Research, Clinical Gastroenterology 16 (2002) 709-731
22. Jacobsen E.B., Hamberg O., Quisorff B., and Ott P. Reduced mitochondrial adenosine triphosphate synthesis in skeletal muscle in patients with Child-Pugh Class B and C cirrhosis. Hepatology 34 (2001) 7-12
23. Kamo N., Muratsugu M., Hongoh R., and Kobatake V. Membrane potential of mitochondria measured with an electrode sensitive to tetraphenyl phosphonium and relationship between proton electrochemical potential and phosphorylation potential in steady state. The Journal of Membrane Biology 49 (1979) 105-121
24. Koteish A., and Diehl A.M. Animal models of steatosis. Seminars in Liver Disease 21 (2001) 89-104
25. Leclercq I.A., Farrell G.C., Field J., Bell D.R., Gonzalez F.J., and Robertson G.R. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine non-alcoholic steatohepatitis. The Journal of Clinical Investigation 105 (2000) 1067-1075
26. Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G., Ahn B.W., Shaltiel S., and Stadtman E.R. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymology 186 (1990) 464-478
27. Mahler H., Pasi A., Kramer J.M., Schulte P., Scoging A.C., and Bar W. Fulminant liver failure in association with the emetic toxin of Bacillus cereus. The New England Journal of Medicine 336 (1997) 1142-1148
28. McClain C.J., Mokshagundam S.P., Barve S.S., Song Z., Hill D.B., Chen T., and Deaciuc I. Mechanisms of non-alcoholic steatohepatitis. Alcohol 34 (2004) 67-79
29. Oliveira P.M.S., Gayotto L.C., Tatai C., Bina B.I.D., Janiszewski M., Lima E.S., Abdalla E.S.P., Lopasso F.P., Laurindo F.R.M., and Laudanna A.A. Oxidative stress in the pathogenesis of non-alcoholic fatty liver disease in rats fed with a choline-deficient diet. Journal of Cellular and Molecular Medicine 6 (2002) 399-406
30. Palmeira C.M., Moreno A.J., and Madeira V.M.C. Interactions of herbicides 2,4-D and dinoseb with liver mitochondrial bioenergetics. Toxicology and Applied Pharmacology 127 (1994) 50-57
31. Palmeira C.M., Ferreira F.M., Rolo A.P., Oliveira P.J., Santos M.S., Moreno A.J., Cipriano M.A., Martins M.I., and Seiça R. Histological changes and impairment of liver mitochondrial bioenergetics after long-term treatment with α-naphthyl-isothiocyanate (ANIT). Toxicology 190 (2003) 185-196
32. Palmeira C.M., and Wallace K.B. Benzoquinone inhibits the voltage-dependent induction of the mitochondrial permeability transition caused by redox-cycling naphthoquinones. Toxicology and Applied Pharmacology 143 (1997) 338-347
33. Pessayre D., Mansouri A., and Fromenty B. Nonalcoholic steatosis and steatohepatitis. Mitochondrial dysfunction in steatohepatitis. American Journal of Physiology, Gastrointestinal and Liver Physiology 282 (2002) G193-G199
34. Petrosillo G., Portincasa P., Grattagliano I., Casanova G., Matera M., Ruggiero F.M., Ferri D., and Paradies G. Mitochondrial dysfunction in rat with nonalchoolic fatty liver. Involvemnt of complex I, reactive oxygen species and cardiolipin. Biochimica et Biophysica Acta 1767 (2007) 1260-1267
35. Rao M.S., and Reddy J.K. Peroxisomal beta-oxidation and steatohepatitis. Seminars in Liver Disease 21 (2001) 43-55
36. Sayeed M.M. Mitochondrial dysfunction in sepsis: a familiar song with new lyrics. Critical Care Medicine 30 (2002) 2780-2781
37. Schatz G. Mitochondria: beyond oxidative phosphorylation. Biochimica et Biophysica Acta 271 (1995) 123-126
38. Schild L., Reinheckel T., Wiswedel I., and Augustin W. Short-term energy production in isolated rat mitochondria by hypoxia/reoxygenation: involvement of oxidative protein modification. The Biochemical Journal 328 (1997) 205-210
39. Singer T.P. Determination of the activity of succinate, NADH, choline and glycerophosphate dehydrogenases. Biochimica et Biophysica Acta 1363 (1994) 100-124
40. Srere P.A. Citrate synthase. Methods in Enzymology vol. 13 (1969), Academic Press, New York pp. 3-11
41. Teodoro J., Rolo A.P., Oliveira P.J., and Palmeira C.M. Decreased ANT content in Zucker fatty rats: Relevance for altered mitochondrial bioenergetics in steatosis. FEBS Letters 580 (2006) 2153-2157
42. Vendemiale G., Grattagliano I., Caraceni P., Caraccio G., Domenicali M., Dall'Agata M., Trevisani F., Guerrieri F., Bernardi M., and Altomare E. Mitochondrial oxidative injury and energy metabolism alteration in rat fatty liver: effect of the nutritional status. Hepatology 33 (2001) 808-815
43. Zafrani E. Non-alcoholic fatty liver disease: an emerging pathological spectrum. Virchows Archiv: An International Journal of Pathology 444 (2004) 3-12
44. Zeisel S.H., and Blusztajn J.K. Choline and human nutrition. Annual Review of Nutrition 14 (1994) 269-296